Sign Up for Free!

Continue Analyzing the page and more.

Already have an Account? Log In

The Trial has ended

Continue Analyzing the page and more.

Jupiter Wellness Inc logo

Jupiter Wellness Inc

US$1.42

US$105.7m

N/A

N/A

Dashboard Funda..tals Deep..lue Prediction Screener Map

Jupiter Wellness Inc Overview

Industry: Personal & Household Products & Services

Sector: Consumer Non-Cyclicals

Jupiter Wellness, Inc., a wellness company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women's sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as CBD Brands, Inc. Jupiter Wellness, Inc. was incorporated in 2018 and is headquartered in Jupiter, Florida.

Jupiter Wellness Inc is evaluated using Mavefund's quality framework: growing earnings, durable profit margins, conservative leverage, strong return on equity, and disciplined share repurchases.

Score

Price History & Performance

Review Jupiter Wellness Inc in context before unlocking the interactive price chart, financial overlays, and downloadable ratio tables.

Recent News



Jupiter Wellness Inc Competitors

Jupiter Wellness Inc operates in the Personal & Household Products & Services industry within the Consumer Non-Cyclicals sector. Unlock the full page to compare peer rankings, valuation quality, profitability, leverage, and growth trends.

Earnings Per Share

EPS quality is one of the core Mavefund signals. Sign up to continue into the detailed EPS, ROE, margin, share buyback, leverage, and financial ratio analysis.

Continue the analysis

Sign up to unlock ROE, net margin, share buyback, leverage, financial ratios, peer charts, and downloads.

View plans
Ticker Image

Jupiter Wellness Inc

US$1.42

US$105.7m

N/A

N/A